Skip to main content
. 2017 Sep 29;12(9):e0185615. doi: 10.1371/journal.pone.0185615

Table 5. Distribution of pathogenic/likely pathogenic mutations with respect to personal history.

Personal history BRCA1 BRCA2 Non-BRCA Total (%)
Ovarian cancer (n = 16) 3 0 1 4 (25.0)
Breast cancer (n = 36) 0 2 1 3 (8.3)
Two cancers (n = 6) 2 1 0 3 (50.0)
Ovarian: BRIP1 (1) p = 0.03*
Breast: RAD50 (1)

6 patients with BC and OC

*Statistically significant, calculated using the Chi-square test.